SGO Annual Meeting on Women's Cancer

Ursula Matulonis Explains the Use of PARP Inhibitors for Ovarian Cancer

March 13th 2017, 9:31pm

Video

Ursula Matulonis, M.D., professor of Medicine, Harvard Medical School, Medical Director of Gynecologic Oncology, Dana-Farber Cancer Institute, explains the benefits of PARP inhibitors for patients with ovarian cancer.

Rucaparib Shows Promising Activity in Recurrent Ovarian Cancer

March 13th 2017, 8:59pm

Article

Elizabeth Swisher, M.D., discusses the ARIEL2 study, which proved that rucaparib may be a promising agent for patients with recurrent ovarian cancer.

Elizabeth Swisher Discusses Rucaparib's Side Effects for Patients With Ovarian Cancer

March 13th 2017, 1:12am

Video

Elizabeth Swisher, M.D., professor, Department of Medicine, Division of Medical Genetics, University of Washington School of Medicine, Breast and Ovarian Cancer Prevention Program, Seattle Cancer Care Alliance, discusses the side effects of rucaparib in the ARIEL2 trial, for patients with relapsed, platinum-sensitive high-grade ovarian carcinoma.